Actively Recruiting
The Prospective Observational Munich Interventional Mitral-Valve Registry
Led by Deutsches Herzzentrum Muenchen · Updated on 2020-10-08
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to observe and collect data on patients undergoing transcatheter mitral or tricuspid valve therapy at a single center in Germany. It focuses on long-term outcomes, particularly mortality over a 5-year period, for individuals with mitral valve regurgitation, mitral valve stenosis, or tricuspid valve regurgitation. The study is observational, meaning it monitors patients receiving care without assigning specific treatments. Participants receive edge-to-edge valve repair as part of their transcatheter valve therapy, which is determined by a heart-team decision to be the best option for their condition. This device-based treatment will be tracked over time as part of the registry. The study started in September 2020 and will continue through January 2031, allowing for long-term follow-up. During the study, researchers will monitor patients' health and survival for up to five years after their valve therapy. Data collected will include mortality outcomes and other health information, without altering standard care. Participants provide informed consent and will be followed through regular medical assessments to contribute to understanding the therapy's long-term effects.
CONDITIONS
Brief Title
The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age above 18 years and consentable
- Diagnosis of mitral valve regurgitation, mitral valve stenosis, tricuspid valve regurgitation, or tricuspid stenosis
- Transcatheter mitral or tricuspid valve therapy recommended as best option by heart-team decision
- Ability to provide written informed consent
You will not qualify if you...
- Inability to fully cooperate with the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo edge-to-edge valve repair as part of their treatment.
1 visit (in-person)
Duration - Up to 5 years
Participants are followed to assess long-term outcomes after valve repair.
Regular visits scheduled according to routine clinical care
Trial Site Locations
Total: 1 location
1
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, Germany, D80636
Actively Recruiting
Research Team
P
Patrick Mayr, MD
J
Joner Michael, Prof
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here